General AML

ESH 2019 | What's new in flow cytometry assessment of MRD?

L:

The AML Global Portal were delighted to speak to Jacqueline Cloos, VU University Medical Center, Amsterdam, NL, during the European School of Hematology (ESH) Translational Research Conference on AML. We asked Jacqueline Cloos: What's new in flow cytometry assessment of MRD? She discusses how clinically validated MRD can be improved to act as a surrogate end-point in clinical trials.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF
Was this article informative? Thank you for your feedback!
100% of people found this article informative